Share this post on:

Product Name: EIF2AK1 antibody
Applications: ICC/IF, IHC-P, WB
Predicted Target Size: 71 kDa (note) (2)
Positive Controls: HeLa , A375
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: eukaryotic translation initiation factor 2-alpha kinase 1
Background: The protein encoded by this gene acts at the level of translation initiation to downregulate protein synthesis in response to stress. The encoded protein is a kinase that can be inactivated by hemin. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq]
Synonyms: HCR antibody, HRI antibody, KIAA1369 antibody, EIF2AK1 antibody, heme sensitive initiation factor 2a kinase antibody, heme-regulated initiation factor 2-alpha kinase antibody, heme-regulated eukaryotic initiation factor eIF-2-alpha kinase antibody, heme-controlled repressor antibody, heme-regulated repressor antibody, heme regulated initiation factor 2 alpha kinase antibody, hemin-sensitive initiation factor 2-alpha kinase antibody, eukaryotic translation initiation factor 2-alpha kinase 1 antibody, heme-regulated inhibitor antibody
Cellular Localization:
CAS NO: 289656-45-7
Product: Balapiravir
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Recombinant protein encompassing a sequence within the center region of human EIF2AK1. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22704955?dopt=Abstract

Share this post on: